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Objectives. The purpose of this study was to measure the
accumulation of labeled albumin and to visualize its distribution
pattern in reperfused infarcted myocardium as a function of time
between onset of reperfusion and administration of the tracer.
Background. Myocardial microvascular injury leads to leakage
of albumin from the intravascular space. Quantitative measure-
ments of GdDTPA-albumin with inversion recovery echoplanar
imaging (IR-EPI) may allow noninvasive monitoring of microvas-
cular injury.
Methods. After 1 h of coronary artery occlusion, 56 rats were
injected with GdDTPA-albumin or 123I-GdDTPA-albumin either
immediately before reperfusion or 1⁄2, 1 or 24 h after reperfusion.
GdDTPA-albumin in blood, normal myocardium and reperfused
infarction was dynamically measured with IR-EPI during 1 h
postinjection (PI). Autoradiograms were obtained at 15 min PI.
Accumulation of labeled albumin in myocardium was expressed as
the ratio of myocardial to blood content.
Results. In normal myocardium, the ratio of changes of relax-
ation rate-ratio (DR1-ratio) was 0.12 6 0.01 and did not change
over 1 h. In reperfused infarction, however, the DR1-ratio in-
creased after administration. Animals given GdDTPA-albumin
before reperfusion exhibited fastest accumulation (DR1-ratio
15 min PI: 0.56 6 0.03) and essentially homogeneous distribution.
The accumulation was slower when administered at 1⁄2, 1 and 24 h
after reperfusion (DR1-ratios 15 min PI: 0.39 6 0.03; 0.31 6 0.04;
0.16 6 0.01; p < 0.001 compared to administration before
reperfusion). Moreover, the tracer accumulated predominantly in
the periphery of the injury zone.
Conclusions. Amount and distribution pattern of labeled albu-
min in reperfused infarction are modulated by duration of reper-
fusion. The accumulation of GdDTPA-albumin can be quantified
by IR-EPI. Thus, IR-EPI may be useful to noninvasively monitor
myocardial microvascular injury in reperfused infarction.
(J Am Coll Cardiol 1998;32:787–93)
©1998 by the American College of Cardiology
Myocardial ischemia causes injury to myocytes and to the
vasculature which supports myocardial perfusion. It is known
that myocyte necrosis precedes damage to the microvascula-
ture, as defined on histology (1). However, injury to the
microvasculature as defined by leakage of plasma macromol-
ecules can be observed even after mild ischemic insult (2,3).
Moreover, this elevated permeability or microvascular injury
seems to progress during reperfusion (4). A noninvasive
method to monitor microvascular injury may be useful in
evaluating myocardial injury.
Microvascular integrity has been studied in vivo with mag-
netic resonance imaging (MRI) using macromolecular gado-
linium chelates like GdDTPA-albumin or GdDTPA-polylysine
(5–7). Macromolecules such as GdDTPA-albumin are retained
in the vasculature in normal myocardium, but leak into the
interstitium in reperfused infarction; this causes a relatively
increased quantity of GdDTPA-albumin within the injured
region (6). On conventional T1-weighted MR images, the
signal intensity in the abnormal region is increased (5,8,9), but
since increased signal intensity on conventional MRI is not
proportional to changes of GdDTPA-albumin concentration,
quantification is complicated (10). However, a proportional
relationship exists between changes in longitudinal relaxivity
(DR1) and changes of GdDTPA-albumin concentration in the
injury zone. Thus, direct DR1 measurements with inversion
recovery echoplanar imaging (IR-EPI) may provide quantifi-
cation of GdDTPA-albumin accumulation in reperfused in-
farcted myocardium (11,12).
The distribution pattern of GdDTPA-albumin in reper-
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fused infarcted myocardium is not always uniform (5–7). An
increased tracer accumulation or hyperenhancement of the
periphery of the infarct zone and a hypoenhancement of the
infarct core have been demonstrated (3,5,6). This pattern of
differential enhancement was more pronounced when the
duration of ischemia increased (7). However, the direct effect
of duration of reperfusion on the amount of GdDTPA-
albumin in reperfused infarction is unclear. The accumulation
of GdDTPA-albumin as a function of delay time between
onset of reperfusion and tracer administration has not been
studied.
Therefore, the specific aims of this study were to 1) validate
the use of IR-EPI and DR1 assessment for quantitative
evaluation of microvascular dysfunction by comparison with a
radionuclide based approach as the gold standard and 2)
define the time course of pathophysiologic changes in myocar-
dial microvasculature and regional blood volume early after
reperfusion.
Methods
Materials. GdDTPA-albumin, a blood pool MRI contrast
agent, was prepared by the method of Ogan et al. (13), in which
the chelate DTPA was covalently linked to human serum
albumin residues. This preparation yields GdDTPA-albumin
with a molecular weight of approximately 92 kDa and T1, T2
relaxivities of 13.7, 18.4 mM21s21, respectively. This agent has
been well characterized as an intravascular blood pool agent
for MR imaging, with a plasma half-life of approximately
90 min (8). In normal myocardium this material is confined to
the intravascular volume.
123I-GdDTPA-albumin was prepared by adding 123iodine
(Cyclotron, Vancouver, Canada) to GdDTPA-albumin taken
from the same stock solution as was used for contrast-
enhanced MRI animals. The labeled product was purified by
placing it over an AG-1X8 anion exchange column.
Animal preparation. Care and maintenance of experimen-
tal animals were in strict accordance with the National Insti-
tutes of Health guidelines. The experimental protocol received
prior approval from the Committee on Animal Research at
this Institution. Female Sprague–Dawley rats (n 5 56; 240 to
310 g; Simonsen Labs Inc., Gilroy, CA) were divided into four
groups (n 5 14 per group) for preparation of myocardial
infarction with varied reflow duration (Fig. 1). Animals were
prepared as described previously (6). Briefly, animals were
anesthetized with sodium pentobarbital (50 mg/kg; IP). Cath-
eters were placed in a jugular vein for administration of
contrast agent or radiotracer and in a carotid artery for
measurement of blood pressure (Gould Transducer, Gould
Inc., Cleveland, OH) and withdrawal of blood. The chest was
opened and the anterior branch of the left coronary artery was
occluded for 1 h followed by reperfusion. This rat model of 1 h
ischemia followed by reperfusion is known to produce substan-
tial myocardial infarction and microvascular injury (6,14).
GdDTPA-albumin (n 5 8) or radiotracer (n 5 6) was admin-
istered 3 min before reperfusion, at 1⁄2 h, or 1 h after
reperfusion for groups 1 to 3, respectively. Animals in group 4
were anesthetized with short-acting anesthesia (8 mg/100 g
xylazine and 0.2 mg/100 g ketamine; IP). Surgical preparation
and coronary occlusion duration were identical to groups 1 to
3. Reperfusion was maintained for 24 h. A total of 87 rats were
prepared in the present study. Thirty-one rats died after
occlusion (15) or reperfusion (13), but before administration of
the contrast agent. No subjects were lost during the measure-
ments. All completed experiments were included in the anal-
ysis.
MRI experiments. Magnetic resonance imaging was con-
ducted on a Bruker Omega CSI 2 Tesla system (Bruker
Instruments Inc., Fremont, CA) as previously described (16).
Each animal was placed supine in a home-built bird cage
resonator; the electrocardiogram signal was obtained from two
subcutaneous copper needles. The field of view contained a
phantom with known T1.
IR-EPI was conducted in the transverse plane to repeatedly
measure T1 of left ventricular chamber blood, normally per-
fused myocardium and reperfused infarction. EPI sequence
parameters were: matrix 64 3 64 points; field of view 50 3
50 mm; slice thickness 2 mm; acquisition time 5 32.7 ms; echo
time (TE) 5 10 ms; pulse delay repetition time minus inversion
time (TR-T1) . 4 3 T1 (fully relaxed).
In each rat, 10 sets of 20 images each with different TI were
Abbreviations and Acronyms
ANOVA 5 analysis of variance
IR-EPI 5 inversion recovery echoplanar imaging
MRI 5 magnetic resonance imaging
R1 and T1 5 longitudinal relaxation rate and time
TI 5 inversion time
TInull 5 inversion time with nil signal arising from tissue
TR and TE 5 repetition and echo times
TTC 5 triphenyltetrazolium chloride
Figure 1. Graph showing the four study groups. GdDTPA-albumin
(n 5 8 in each group) or 123I-GdDTPA-albumin (n 5 6 in each group)
were injected before reperfusion (group 1); after 1⁄2 h (group 2); after
1 h (group 3); after 24 h of reperfusion (group 4). Magnetic resonance
imaging in each group was performed over a 1-h period, or hearts were
excised 15 min after injection and autoradiography performed. Solid
bar 5 time of coronary artery occlusion (1 h); hatched bar 5 time
during reperfusion at which GdDTPA-albumin or 123I-GdDTPA-
albumin were injected and MRI or autoradiography was performed.
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acquired before and at 4, 9, 14, 19, 24, 29, 39, 49 and 59 min
after administration of GdDTPA-albumin (0.03 mmol Gd/kg).
These image sets were used to measure regional T1 values and
calculate DR1 as described previously (16). At the conclusion
of T1 measurements, a conventional T1-weighted spin-echo
image (TR ; 300 ms; TE 5 25 ms; raw data matrix 256 3 128
zero filled to 256 3 256) was acquired at the same midven-
tricular level.
After MR measurements, hearts were excised, rinsed, sliced
at the midventricular level and stained by soaking in a 2%
solution of triphenyltetrazolium chloride (TTC) at 37°C for
8 min to define the infarction. This staining procedure provides
brick-red coloration of normal myocardium, whereas infarcted
myocardium is unstained (14).
Radioisotope experiments. Six rats per group were exam-
ined for distribution of 123I-GdDTPA-albumin (500 mCi). The
tracer was allowed to circulate for 15 min since MRI data
demonstrated maximal differences of DR1-ratios among
groups at that time. A sample of blood (0.5 ml) was then
withdrawn from the carotid artery for radioactivity measure-
ments. The coronary artery was reoccluded and phthalocya-
nine blue dye (particle size of 7.4 6 3.2 mm) was administered
intravenously to define the area at risk (17). The heart was
excised and sliced at the midventricular level. Samples from
both the unstained area at risk and the blue-stained, normally
perfused myocardium were taken from the apical portion of
the transsected heart. Samples were weighed and radioactivity
counted in a gamma-counter was measured (Searle-Analytic
Inc., Tampa, Florida). The basal portion of the transsected
heart was placed in embedding medium (Tissue-Tek, Sakura
Finetechnical Co. LTD, Tokyo), immediately frozen in dry ice
and sectioned (20 mm). Sections were placed on a photostimu-
lable storage phosphor imaging plate (Molecular Dynamics,
Sunnyvale, CA) to obtain digital autoradiograms. These were
evaluated using software (ImageQuant, Molecular Dynamics,
Sunnyvale, CA) to determine the distribution of radioactivity
in these slices.
MRI data analysis. The inversion time with nil signal
(TInull) was determined for normally perfused myocardium,
reperfused infarcted myocardium, ventricular blood and phan-
tom using an image analysis program (NIH-image). T1 values
and DR1-ratios were calculated as described previously (16):
R1 5
1
T1
5
ln2
TInull
[1]
DR1 ratio 5
DR1tissue
DR1blood
5
~R1postcontrast 2 R1precontrast!tissue
~R1postcontrast 2 R1precontrast!blood
[2]
DR1-ratios were plotted vs. time. Regional blood volume
was estimated by fitting the DR1-ratios of reperfused infarcted
and of normal myocardium and by extrapolating the fitted
curves to the time of GdDTPA-albumin injection. Myocardial
blood volumes of the infarcted regions were expressed as a
percentage of normal myocardium.
Radioisotope data analysis. The radioactivity ratio of nor-
mally perfused myocardium was calculated as:
~counts/min z g!normal myocardium/~counts/min z g!blood [3]
The injury zone was defined by a count density of $2 SD
higher than the mean of normally perfused myocardium. The
radioactivity ratio of injured myocardium was calculated as:
counts/min z gnormal myocardium
counts/min/gblood
3
count densityinjury
count densitynormal
[4]
The same slices were scanned with a flatbed scanner
(Epson, Seiko Epson Corp., Japan); data were processed on a
Macintosh computer with image analysis software (NIH-
image). The area at risk defined as unstained tissue was
measured and expressed as a percentage of the total cross-
sectional area of the left ventricular slice.
Statistical analysis. All values are expressed as mean 6
SEM. Comparisons among groups at 15 min after contrast
administration were made with a one-way analysis of variance
(ANOVA). If the analysis showed an overall p , 0.05 value,
Scheffe´’s test was implemented as post hoc test. For single
comparisons a paired Student’s t test was used. A p value of
,0.05 was considered significant.
Results
Hemodynamic data. Administration of 123I-GdDTPA-
albumin caused no significant changes in heart rate (309 6 12
vs. 298 6 12 beats/min) or in systolic (112 6 6; 120 6
5 mm Hg), diastolic (87 6 5; 92 6 5 mm Hg) or mean (98 6
6; 105 6 5 mm Hg) blood pressures. Heart rate and blood
pressure did not differ among the groups.
MRI data. Precontrast T1 of infarction (1.13 6 0.03 s) was
longer than that of normal myocardium (0.92 6 0.02 s) (p ,
0.05; Student’s paired t test). After GdDTPA-albumin admin-
istration, T1 of blood, reperfused infarction and normal myo-
cardium decreased by ninefold, twofold to fourfold and two-
fold, respectively. However, regional variation of T1
shortening occurred, which reflects regional variations of
GdDTPA-albumin content. Representative IR-EPI images
obtained at identical anatomical level but with different TI
settings demonstrate regional differences in GdDTPA-albumin
content (Fig. 2). The shortest TInull was found in the blood
pool, indicating greatest concentration of GdDTPA-albumin.
The TInull of reperfused infarction decreased steadily with time
after injection of GdDTPA-albumin, reflecting accumulation
of the tracer.
The accumulation of GdDTPA-albumin in reperfused in-
farction was fastest when administered immediately before
reperfusion (DR1-ratio at 15 min PI: 0.56 6 0.03). The
accumulation was slower when administered at 1⁄2, 1 and 24 h
after reperfusion (DR1-ratios at 15 min PI: 0.39 6 0.03; 0.31 6
0.04; 0.16 6 0.01; p , 0.001 compared to administration
immediately before reperfusion; one-way ANOVA with post
hoc Scheffe´’s test).
The DR1-ratio of normal myocardium (0.12 6 0.01) did not
differ among the experimental groups and did not change
significantly during the observation period of 1 h after
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GdDTPA-albumin administration. Reperfused infarction,
however, was characterized by increasing DR1 ratios after
GdDTPA-albumin administration (Fig. 3), reflecting accumu-
lation of the tracer in the injury zone. Accumulation was
maximal when GdDTPA-albumin was injected immediately
before reperfusion. The accumulation declined as the time of
tracer injection was delayed during the reperfusion period
(Fig. 3).
Radioisotope data. The radioactivity ratios in normal and
injured myocardium, as measured after 123I-GdDTPA-
albumin administration, were similar to the DR1-ratios of
IR-EPI (Fig. 4). Both MR contrast media and radiotracer
accumulated in injured myocardium, but accumulation de-
clined with increasing delay between onset of reperfusion and
injection of the tracers (Fig. 4). The distribution of 123I-
GdDTPA-albumin in the injury zone was essentially uniform
when administered before reperfusion (Fig. 5, A). However, in
hearts subjected to delayed tracer administration, 123I-
GdDTPA-albumin was distributed in a heterogeneous fashion
in the injury zone (Fig. 5, B to D). As the delay increased, less
123I-GdDTPA-albumin was seen in the core of infarction (Fig.
5, D).
Regional blood volume. At onset of reperfusion the appar-
ent blood volume of infarcted myocardium was substantially
increased (280% 6 14% of normally perfused myocardium),
consistent with hyperemia (Fig. 6). The regional blood volume
progressively declined during reperfusion. At 1⁄2 h and 1 h
there was no significant difference in blood volume between
normal and postischemic myocardium (105% 6 11% and
106% 6 16%, respectively). At 24 h after reperfusion the
regional blood volume was 69% 6 5% of that of normal
myocardium.
The DR1 ratio of normal myocardium was 0.12 6 0.01 and
did not change significantly during 1 h of observation, which is
consistent with a myocardial blood volume of approximately
12 ml/100 g (15,18). This value is similar to previously reported
results as measured with various methods (19,20).
Figure 2. Axial IR-EPI of a rat heart acquired at the same anatomical
level but with different TI settings. After 1 h coronary occlusion and
24 h reperfusion, GdDTPA-albumin was administered; IR-EPI were
acquired 4 min later. A strong negative signal was observed for blood
and the entire myocardium with TI 5 20 ms (top left panel). Nil signal
was obtained for blood at TI 5 70 ms from left ventricular blood (LV
in top right panel), for normal myocardium at TI 5 320 ms (arrow-
heads in lower left panel) and for reperfused infarction at TI 5 470 ms
(arrows in lower right panel). Regions with faster T1 relaxation, that
is, greater Gadolinium concentration, exhibit nil signal at shortest TI
setting. Thus, Gadolinium concentration in blood . in normal myo-
cardium . in reperfused infarction at 4 min after administration.
Figure 3. DR1 ratio over time postinjection of GdDTPA-albumin in
normal and reperfused infarcted myocardium. GdDTPA-albumin was
injected before reperfusion, at 1⁄2, 1 or 24 h of reperfusion. Note that
the accumulation of GdDTPA-albumin was fastest when given before
reperfusion. The accumulation was slower when administered at 1⁄2, 1
and 24 h after reperfusion.
Figure 4. DR1 and radioactivity ratios of reperfused infarct/blood (A)
and normal/blood (B). When tracers were injected before reperfusion,
at 1⁄2, 1 or 24 h of reperfusion, there were no significant differences
between DR1- and radioactivity-ratios. However, both ratios decreased
when the tracers were administered after reperfusion as compared to
administration before reperfusion (*p , 0.01), and decreased further
at 24 h of reperfusion as compared to 1 h of reperfusion (†p , 0.05).
Solid bars 5 DR1-ratio; white bars 5 radioactivity-ratio.
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Postmortem findings. The area at risk defined by phthalo-
cyanine blue was 47.1% 6 1.5% of the left ventricular surface
area and did not differ significantly among the groups. In MR
experiments, the shape and location of infarction on T1-
weighted spin echo images was similar to the TTC negative
region (Fig. 7). The current model of 1 h of ischemia followed
by reperfusion produces substantial myocardial infarction evi-
dent as TTC negative area, which is in agreement with previous
work (7). All animals subjected to 24-h reperfusion exhibited
substantial hemorrhage (Fig. 7). Intramyocardial hemorrhage
was less frequent when reflow was 2 h or less.
Discussion
The major findings of the current study are 1) accumulation
of GdDTPA-albumin as an indicator of ischemic microvascular
injury can be quantified by IR-EPI; 2) MR and radioisotope
measurements agree; 3) accumulation of GdDTPA-albumin in
reperfused infarcted myocardium decreases with duration of
reperfusion; 4) distribution of macromolecules in the injury
zone is essentially uniform early after reperfusion, but later
during reperfusion, GdDTPA-albumin accumulates predomi-
nately at the border of the injury zone; 5) reperfusion causes
progressive decline of blood volume in reperfused infarction.
Regional blood volume. Substantial elevation of the blood
volume in infarction at onset of reperfusion suggests a hyper-
emic reaction, which subsided 30 min after reperfusion. Similar
findings have been described by other investigators (21,22).
During reperfusion the blood volume in the infarct declined
progressively. At 24 h after reperfusion the blood volume in
the infarct was less than that of normal myocardium, which is
consistent with occurrence of the “no reflow” phenomenon as
described by Kloner et al. (23,24). The progressive decline of
the blood volume in reperfused infarction suggests a progres-
sion of the no reflow phenomenon during reperfusion. This
finding is consistent with results from Ambrosio et al. (22), who
monitored serial changes in regional blood flow in dogs
subjected to prolonged reperfusion using radioactive micro-
spheres. These investigators observed progression of the no
reflow phenomenon during reperfusion; progressive impair-
ment of flow in postischemic myocardium was associated with
capillary plugging (22). Recent contrast-enhanced MR studies
confirmed the presence of microvascular obstruction in acutely
reperfused infarction in patients (25).
Role of edema, lymphatic clearance and capillary perme-
ability. Edema associated with elevated tissue pressure
evolves in reperfused infarction (26). Elevated tissue pressure
may result in compression force on the vasculature, ensuing
declining blood volume and aggravating circulation distur-
bances (27). Edema is promoted by extravasation of macro-
molecules into the extravascular space and by degradation of
the extracellular matrix (28). An elevated tissue pressure can
impede the accumulation of macromolecules because trans-
port of large molecules is predominantly driven by motion of
bulk fluid (convection), which is governed by pressure gradi-
ents (29). Thus, in postischemic myocardium, GdDTPA-
albumin would encounter a low transcapillary pressure gradi-
ent, and extravasation driven by convective forces would be
reduced. Lymphatic clearance in postischemic myocardium is
elevated, evidenced as increased flow and protein content of
lymphatic fluid in dogs by 53% and 67%, respectively (30). This
initial elevation, however, is followed by a gradual decline in
lymphatic clearance as reperfusion evolves (31). The route for
extravasation of albumin into the extravascular space is likely
interendothelial gaps which increase during hypoxia (32) and
reoxygenation (4) or reperfusion (33,34).
Regional distribution of labeled albumin. On autoradiog-
raphy, an essentially uniform distribution of 123I-GdDTPA-
Figure 6. Blood volume of ischemically injured myocardium at various
durations of reperfusion. Values are expressed as percentage of the
blood volume of normal myocardium. The elevated blood volume at
onset of reperfusion likely represents postischemic hyperemia; the
decreased blood volume after 24 h of reperfusion may be the conse-
quence of edema and external compression of the microvasculature,
microvascular plugging and swelling of endothelial cells.
Figure 5. Autoradiograms of midventricular slices of hearts subjected
to 1 h of coronary occlusion and reperfusion. 123I-GdDTPA-albumin
was injected either before reperfusion (A), at 1⁄2 (B), at 1 (C) or at 24 h
(D) after reperfusion. The accumulation of labeled albumin in the
anterolateral wall of the left ventricle indicates vascular injury. Maxi-
mal and essentially homogeneous accumulation of labeled albumin
occurs when administered before reperfusion (A). When 123I-
GdDTPA-albumin was administered later during reperfusion, less
indicator was observed in the infarct core (D, arrowheads).
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albumin was seen only when the tracer was administered
before reperfusion. When administered after reperfusion,
there was less labeled albumin in the core of the injury zone
than in the periphery. This pattern was more pronounced when
the administration of the tracer was delayed after reperfusion.
These findings are in agreement with a previous study where
hearts were subjected to 1 h of occlusion and 1 h of reperfusion
before biotin-labeled GdDTPA-albumin was administered (6).
These investigators compared histologic analysis and T1-
weighted spin echo images and found dispersion of biotin-
GdDTPA-albumin throughout the interstitium and the myo-
cytes; however, less tracer was detectable with either method in
the infarct core as opposed to the rim (6). Other investigators
studied the effect of various duration of ischemia followed by
2 h of reperfusion before administration of GdDTPA-albumin
(7). They described a similar pattern on T1-weighted spin echo
MR images ex vivo with a bright border zone and a less
enhanced central core which increased in size with increasing
(30 to 75 min) duration of ischemia (7).
In vivo assessment of microvascular injury. In distinction
to previous research, the current study employed IR-EPI to
measure the accumulation of GdDTPA-albumin in isch-
emically injured myocardium. Since IR-EPI allows quantitative
measurements, it may be used to assess the potential of various
new therapeutic agents designed to protect the myocardial
vasculature during ischemia and reperfusion. The current
study, however, is the first to demonstrate noninvasively in a
quantitative fashion that the accumulation of macromolecules
in postischemic myocardium declines when the administration
is delayed up to 24 h after reperfusion.
Postinfarct alterations of microvascular integrity have re-
cently been shown by Wu et al. (25) in patients using
GdDTPA-enhanced MRI. These investigators performed se-
rial measurements after contrast injection and demonstrated
that microvascular obstruction, defined as hypoenhancement
at 1 to 2 min and hyperenhancement at 5 to 10 min after
injection, is predictive of poorer outcome. Other imaging
modalities like positron emission tomography (35) and con-
trast echocardiography (36,37) have been used to assess mi-
crovascular injury in reperfused infarction. Myocardial-
contrast echocardiography (36) has correlated the presence of
contrast defects with poor functional recovery despite restored
flow in the infarct-related artery. Unlike MRI, however, this
method currently requires intracoronary injection of micro-
bubbles, necessitating cardiac catheterization.
Limitation. The blood volume estimates in the current
study were based on the assumption that GdDTPA-albumin is
present only in the intravascular compartment at the moment
of injection. Therefore, extrapolation of DR1 ratio data back to
the moment of injection was assumed to reflect the blood
volume. However, severe vascular damage in the injury zone
may allow substantial extravasation of GdDTPA-albumin im-
mediately during first pass. Thus, overestimation of the true
blood volume may occur.
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